Free Access
No Access
Partial Access |
|
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting
A Consensus Document of the European Society of Cardiology Working Group onThrombosis, endorsed by the European Heart Rhythm Association [EHRA] and the European Association of Percutaneous Cardiovascular Interventions [EAPCI]
G. Y. H. Lip, K. Huber (1), F. Andreotti (2), H. Arnesen (3), K. J. Airaksinen (4), T. Cuisset (5), P. Kirchhof (6), F. Marín (7)
(1) 3rd Department of Medicine, Cardiology and Emergency Medicine, Wilhelminenhospital, Vienna, Austria; (2) Institute of Cardiology, Gemelli University Hospital, Rome, Italy; (3) Department of Cardiology, Oslo University Hospital, Ullevål, Oslo, Norway; (4) Department of Medicine, Turku University Hospital, Turku, Finland; (5) Department of Cardiology, CHU Timone, Marseille, France; (6) Department of Cardiology and Angiology, Universitätsklinikum Münster, Münster, Germany; (7) Department of Cardiology, Hospital Universitario Virgen de la Arrixaca, Ctra Madrid-Cartagena s/n, Murcia, Spain
Summary
There remains uncertainty over optimal antithrombotic management strategy for patients with atrial fibrillation (AF) presenting with an acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting. Clinicians need to balance the risk of stroke and thromboembolism against the risk of recurrent cardiac ischaemia and/or stent thrombosis, and the risk of bleeding. This consensus document comprehensively reviews the published evidence and presents a consensus statement on a ‘best practice’ antithrombotic therapy guideline for the management of antithrombotic therapy in such AF patients.Keywords
stenting, Acute coronary syndrome, percutaneous coronary intervention, warfarin, antithrombotic therapy, Arial fibrillation
DOI
http://dx.doi.org/10.1160/TH09-08-0580You may also be interested in...
| 1. | ||
H. Hölschermann Hämostaseologie 2007 27 5: 319-325 | ||
| 2. | ||
H. Hölschermann Hämostaseologie 2006 26 2: 106-113 | ||
| 3. | ||
T. Wichter Hämostaseologie 2006 26 2: 138-146 | ||
Articles
You've 110 Article(s) in your Basket.
TH 107.5
Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...
TH 107.4
The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....
Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis
Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...